Literature DB >> 2483857

Subependymoma of the septum pellucidum radiologically indistinguishable from cavernous angioma--case report.

T Yamasaki, H Kikuchi, J Yamashita, Y Goto, H Yamabe.   

Abstract

A case of subependymoma of the septum pellucidum in a 54-year-old female is presented. Computed tomography and magnetic resonance imaging revealed a partially calcified mass with intratumoral hematomas, and cerebral angiograms disclosed a relatively hypovascular lesion. Preoperatively, a cavernous angioma was suspected. The tumor was removed, and histological examination proved it to be a subependymoma containing a fine fibrillary matrix. On immunohistochemical analysis, both the matrix and the tumor cells were positive for glial fibrillary acidic protein staining.

Entities:  

Mesh:

Year:  1989        PMID: 2483857     DOI: 10.2176/nmc.29.1020

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  3 in total

1.  Clinicopathological study of seven cases of symptomatic supratentorial subependymoma.

Authors:  So-Hyang Im; Sun Ha Paek; Yoon-La Choi; Je G Chi; Dong Gyu Kim; Hee-Won Jung; Byung-Kyu Cho
Journal:  J Neurooncol       Date:  2003-01       Impact factor: 4.130

2.  Endoscope-assisted microsurgery for tumors of the septum pellucidum: surgical considerations and benefits of the method in the treatment of four serial cases.

Authors:  M Fratzoglou; A R Leite dos Santos; I Gawish; A Perneczky
Journal:  Neurosurg Rev       Date:  2004-05-12       Impact factor: 3.042

3.  MR Spectroscopy to Distinguish between Supratentorial Intraventricular Subependymoma and Central Neurocytoma.

Authors:  Fumiaki Ueda; Hiroyuki Aburano; Yasuji Ryu; Yuichi Yoshie; Mitsutoshi Nakada; Yutaka Hayashi; Osamu Matsui; Toshifumi Gabata
Journal:  Magn Reson Med Sci       Date:  2016-12-12       Impact factor: 2.471

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.